DIS3L, cytoplasmic exosome catalytic subunit, is essential for development but not cell viability in mice.
- Michał Brouze1,
- Marcin Szpila1,
- Areta Magdalena Czerwińska1,
- Wiktor Antczak1,
- Seweryn Mroczek2,
- Tomasz Kuliński1,
- Anna Maria Hojka-Osińska1,
- Dominik Cysewski3,
- Olga Gewartowska1,
- Dorota Adamska3,
- Jakub Gruchota1,
- Ewa Borsuk1 and
- Andrzej Dziembowski1,4
- 1 International Institute of Molecular and Cell Biology in Warsaw;
- 2 University of Warsaw, Faculty of Biology;
- 3 Institute of Biochemistry and Biophysics Polish Academy of Sciences
- ↵* Corresponding author; email: adziembowski{at}iimcb.gov.pl
Abstract
Among numerous enzymes involved in RNA decay, processive exoribonucleases are the most prominent group responsible for the degradation of the entire RNA molecules. The role of mammalian cytoplasmic 3’-5’ exonuclease DIS3L at the organismal level remained unknown. Herein, we established knock-in and knock-out mouse models to study DIS3L functions in mice. DIS3L in mice is indeed a subunit of the cytoplasmic exosome complex, the disruption of which leads to severe embryo degeneration and death in mice soon after implantation. These changes could not be prevented by supplementing extraembryonic tissue with functional DIS3L through the construction of chimeric embryos. Preimplantation Dis3l-/- embryos were unaffected in their morphology and ability to produce functional embryonic stem cells, showing that DIS3L is not essential for cell viability. There were also no major changes at the transcriptome level for both embryonic stem cells and blastocysts, as revealed by RNA sequencing experiments. Notably, however, Dis3l knock-out led to inhibition of the global protein synthesis. These results point to the essential role of DIS3L in mRNA metabolism, which is crucial for proper protein synthesis during embryo development.
Keywords
- Received December 9, 2024.
- Accepted January 11, 2025.
- Published by Cold Spring Harbor Laboratory Press for the RNA Society
This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.










